PCRonline

TAVI with the Edwards family of valves has emerged as a fast, predictable & robust procedure with proven durability

Chairpersons: Thierry Lefèvre, Hermann Reichenspurner

Objectives:

To understand the status of TAVI in 2015
To learn about the latest Edwards TAVI valves
To appreciate the breadth & depth of clinical data

Lectures

Session objectives

T. Lefèvre

TAVI is the treatment of choice for symptomatic AS in octogenarians

A. Linke

Case demonstration from Clinique Pasteur, Toulouse, France


Shorter hospital stays for patients are becoming a reality

H. Eltchaninoff

Case demonstration from Clinique Pasteur, Toulouse, France


Moving into younger patients: have we overcome the durability concern?

M.B. Leon

Session evaluation and key learnings

H. Reichenspurner

Share

More from Edwards Lifesciences

Visit website